Literature DB >> 3488371

Immunocytochemical characterisation of the immune reaction in the central nervous system in multiple sclerosis. Possible role for microglia in lesion growth.

M N Woodroofe, A S Bellamy, M Feldmann, A N Davison, M L Cuzner.   

Abstract

As there is evidence that in multiple sclerosis T-cell activation occurs in the central nervous system rather than outside, the inflammatory lesion may be extended through antigen presentation by cells at the edge of the plaque. In this study we present an immunocytochemical report on CNS tissue from an active case of MS, with an analysis of the distribution of CD4 and CD8 binding T cells and the expression of class I and II MHC determinants in plaques and white matter. Perivascular cuffs of early lesions, as judged by hypercellularity and minimal demyelination, contained activated T (Tac+) cells, which reacted with an anti-IL-2 monoclonal antibody. Thus sufficient T-cell growth factor would appear to be present to fuel the immune reaction in a growing lesion. The preponderance of T cells of the cytotoxic/suppressor (CD8) phenotype in the CNS parenchyma was found in conjunction with widespread staining of class I MHC antigen, a prerequisite for activity of cytotoxic T cells. Potential antigen presenting cells were demonstrated in MS plaques with a monoclonal antibody against the cytoplasmic, invariant chain of class II MHC. Macrophages and astrocytes, contributed to the staining in the hypercellular plaque border while the distribution of class II+ microglia in white matter suggest they may also be of importance in local antigen presentation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488371     DOI: 10.1016/0022-510x(86)90100-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  35 in total

Review 1.  What do we know about the mechanism of action of disease-modifying treatments in MS?

Authors:  Hans-Peter Hartung; Amit Bar-Or; Yannis Zoukos
Journal:  J Neurol       Date:  2004-09       Impact factor: 4.849

2.  Immune regulatory CNS-reactive CD8+T cells in experimental autoimmune encephalomyelitis.

Authors:  Nathan R York; Jason P Mendoza; Sterling B Ortega; Andrew Benagh; Andrew F Tyler; Mihail Firan; Nitin J Karandikar
Journal:  J Autoimmun       Date:  2010-02-20       Impact factor: 7.094

3.  Lectin labelling of amoeboid microglial cells in the brain of postnatal rats.

Authors:  C Kaur; E A Ling; W C Wong
Journal:  J Anat       Date:  1990-12       Impact factor: 2.610

4.  Cathepsin D activity in human peripheral blood mononuclear leukocytes.

Authors:  C T Bever; K D Morgan; J N Whitaker
Journal:  Inflammation       Date:  1989-06       Impact factor: 4.092

Review 5.  Macrophages in CNS remyelination: friend or foe?

Authors:  L T Diemel; C A Copelman; M L Cuzner
Journal:  Neurochem Res       Date:  1998-03       Impact factor: 3.996

6.  The need for a new strategy for the treatment of multiple sclerosis.

Authors:  A N Davison
Journal:  J Neurol       Date:  1988-07       Impact factor: 4.849

Review 7.  Antigen-specific therapies for the treatment of autoimmune diseases.

Authors:  D A Hafler; H L Weiner
Journal:  Springer Semin Immunopathol       Date:  1995

8.  Immunophenotypic features of epiplexus cells and their response to interferon gamma injected intraperitoneally in postnatal rats.

Authors:  J Lu; C Kaur; E A Ling
Journal:  J Anat       Date:  1994-08       Impact factor: 2.610

9.  Expression of major histocompatibility complex and leukocyte common antigens in amoeboid microglia in postnatal rats.

Authors:  E A Ling; C Kaur; W C Wong
Journal:  J Anat       Date:  1991-08       Impact factor: 2.610

Review 10.  Modeling the heterogeneity of multiple sclerosis in animals.

Authors:  Sarah B Simmons; Emily R Pierson; Sarah Y Lee; Joan M Goverman
Journal:  Trends Immunol       Date:  2013-05-21       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.